Blood pressure control among adults with hypertension living with HIV and without HIV in Tanzania and Uganda: a secondary analysis of the INTE-AFRICA trial

Hypertension is an increasingly important comorbidity among people living with HIV (PLHIV) in sub-Saharan Africa. Although regular HIV clinic attendance, more frequent healthcare contact, and established chronic care systems might be expected to support better blood pressure (BP) control, existing evidence remains inconsistent. We compared BP outcomes between PLHIV and those without HIV within a common trial setting. We conducted a secondary analysis of a pragmatic cluster-randomised trial undertaken in 32 health facilities in Tanzania and Uganda between 30 June 2020 and 1 April 2021. Adults aged ≥ 18 years with hypertension were included, irrespective of HIV or diabetes status, and followed for 12 months under integrated or standard care. The primary outcome was BP control at 12 months, defined as < 140/90 mmHg. Generalized estimating equations (GEE) were used to compare outcomes by HIV status, accounting for clustering at the health-facility level and adjusting for age, sex, trial arm and site location. Among 2,391 participants with 12-month blood pressure data, 453 were PLHIV and 1,938 were without HIV. Blood pressure control was achieved in 32.7% (148/453) of PLHIV compared with 46.9% (909/1,938) of those without HIV, with an adjusted risk difference of 14.5% points (95% CI 9.5, 19.5) favouring participants without HIV. At 12 months, mean systolic BP was higher among PLHIV than those without HIV (144.4 [SD 23.6]) mmHg vs. 139.5 (SD 20.9) mmHg, with an adjusted mean difference of -5.6 mmHg (95% CI -8·1, -3·1). Mean diastolic BP was also higher among PLHIV (92.6 [SD 14.5]) mmHg vs. 85.6 (SD 11.8) mmHg, with an adjusted mean difference of -5.1 mmHg (95% CI -6·7, -3·5). These differences were present at enrolment and remained across age and sex groups during follow-up. Participants living with HIV entered the trial with poorer BP control profiles than those without HIV, and these differences remained evident at 12 months. This persistent disparity highlights the need to strengthen long-term hypertension management among PLHIV and to further integrate hypertension care within HIV services in these settings.

Authors

Institutions

Publication Details

Journal
AIDS Research and Therapy
Published
2026-11-16
DOI
https://doi.org/10.1186/s12981-026-00987-x
Primary Topic
Blood Pressure and Hypertension Studies
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Blood pressure control among adults with hypertension living with HIV and without HIV in Tanzania and Uganda: a secondary analysis of the INTE-AFRICA trial

Josephine Birungi, Sayoki Mfinanga, Shabbar S. Jaffar, Duolao Wang et al.
1 links
AIDS Research and Therapy
Blood Pressure and Hypertension Studies
article

Blood pressure control among adults with hypertension living with HIV and without HIV in Tanzania and Uganda: a secondary analysis of the INTE-AFRICA trial

Josephine Birungi, Sayoki Mfinanga, Shabbar S. Jaffar, Duolao Wang, Anupam V. Garrib, Kaushik Laxmidas Ramaiya, Moffat Nyirenda, Marie Claire Van Hout, Sokoine Lesikari Kivuyo, Jeffrey Victor Lazarus, Erik van Widenfelt
article en

Abstract

Hypertension is an increasingly important comorbidity among people living with HIV (PLHIV) in sub-Saharan Africa. Although regular HIV clinic attendance, more frequent healthcare contact, and established chronic care systems might be expected to support better blood pressure (BP) control, existing evidence remains inconsistent. We compared BP outcomes between PLHIV and those without HIV within a common trial setting. We conducted a secondary analysis of a pragmatic cluster-randomised trial undertaken in 32 health facilities in Tanzania and Uganda between 30 June 2020 and 1 April 2021. Adults aged ≥ 18 years with hypertension were included, irrespective of HIV or diabetes status, and followed for 12 months under integrated or standard care. The primary outcome was BP control at 12 months, defined as < 140/90 mmHg. Generalized estimating equations (GEE) were used to compare outcomes by HIV status, accounting for clustering at the health-facility level and adjusting for age, sex, trial arm and site location. Among 2,391 participants with 12-month blood pressure data, 453 were PLHIV and 1,938 were without HIV. Blood pressure control was achieved in 32.7% (148/453) of PLHIV compared with 46.9% (909/1,938) of those without HIV, with an adjusted risk difference of 14.5% points (95% CI 9.5, 19.5) favouring participants without HIV. At 12 months, mean systolic BP was higher among PLHIV than those without HIV (144.4 [SD 23.6]) mmHg vs. 139.5 (SD 20.9) mmHg, with an adjusted mean difference of -5.6 mmHg (95% CI -8·1, -3·1). Mean diastolic BP was also higher among PLHIV (92.6 [SD 14.5]) mmHg vs. 85.6 (SD 11.8) mmHg, with an adjusted mean difference of -5.1 mmHg (95% CI -6·7, -3·5). These differences were present at enrolment and remained across age and sex groups during follow-up. Participants living with HIV entered the trial with poorer BP control profiles than those without HIV, and these differences remained evident at 12 months. This persistent disparity highlights the need to strengthen long-term hypertension management among PLHIV and to further integrate hypertension care within HIV services in these settings.

AIDS Research and Therapy
The AIDS Support Organization (UG), NewYork–Presbyterian Hospital (US), Nanchang University (CN), City University of New York (US), Liverpool School of Tropical Medicine (GB), La Trobe University (AU), Mulago Hospital (UG), London School of Hygiene & Tropical Medicine (GB), Barcelona Institute for Global Health (ES), First Affiliated Hospital of Nanchang University (CN), National Institute for Medical Research (TZ), South East Technological University (IE), Weill Cornell Medical Center (US), MRC/UVRI & LSHTM Uganda Research Unit (UG), University College London (GB), Universitat de Barcelona (ES), Medical Research Council (GB), Uganda Virus Research Institute (UG)
European Commission
Good health and well-being
Blood Pressure and Hypertension Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon